News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


More treatment options for Kiwis with type 1 diabetes

Media Release EMBARGOED UNTIL 12:01am, Thursday 17 January 2013

More treatment options for Kiwis with type 1 diabetes now funded

Medtronic insulin pumps and insulin pump consumables now available through PHARMAC

New Zealand diabetes specialists and people with type 1 diabetes have today welcomed the availability of a second supplier to PHARMAC for insulin pumps and insulin pump consumables, citing the availability for choice of device technologies as a significant step forward in improving management of the condition in New Zealand.

Commenting on the addition of Medtronic insulin pumps and insulin pump consumables through PHARMAC, Associate Professor Paul Hofman said: “It cannot be assumed that even though people are diagnosed with the same health condition that one specific device will give everyone the best health outcomes – health management is not a ‘one size fits all’ option. The addition of a second supplier to PHARMAC means that people with type 1 diabetes who qualify for an insulin pump can decide on an option that is most appropriate for their needs."

The MiniMed Paradigm™ Insulin Pump Model 522 or 722 now reimbursed by PHARMAC, provides REALTime glucose readings updated every five minutes, 24 hours a day. These readings help patients take immediate action in the management of their diabetes, reducing the severity and duration of hypo and hyperglycaemiai, ii, iii,iv and protect against longterm health complications associated with these conditions such as eye, heart and kidney disease.v,vi The pump also enables more precise dosing of insulin. This is an important consideration for many people with type 1 diabetes, especially young children, who require small, frequent doses of insulin which are impractical and virtually impossible to deliver via an injection.

“The decision by PHARMAC is a positive step forward in encouraging insulin pump use in New Zealand and I hope it prompts children, families and adults with type 1 diabetes to discuss this therapy option with their general practioners or diabetes team specialists,” said Assoc Prof Hofman “An insulin pump may be the right choice for anyone who takes insulin and wants better glucose control, more convenience and more flexibility to improve their quality of life."

Research shows that people on insulin pump therapy are six times more likely to achieve the target HbA1c (Glycated Haemoglobin) level than people on multiple daily injections with long acting insulin. This is important given that people with diabetes who keep their glucose at nearnormal levels significantly reduce their risk of longterm complications to live healthier and longer.

For patients who have previously purchased a Medtronic pump at their own cost, the decision now means they can access reservoirs and infusion sets that work in conjunction with their pump to delivery therapy, through pharmacies at no charge.

Amy DaneshClough, parent of 11 year old Jonnie, who has been diagnosed with type 1 diabetes for ten years and currently uses an insulin pump, believes the funding is a step forward in bringing New Zealand in line with the rest of the world – but still there is a long way to go.

“We have attended family camps for children with type 1 diabetes overseas where 95 per cent of the children have an insulin pump to manage their diabetes and only a small number use multiple daily injections. I believe the reverse is true in New Zealand, largely due to the cost of accessing the therapy.

“While we have paid for an insulin pump ourselves, funding for the ongoing consumables will be a great saving for us and I hope will enable more people with type 1 diabetes to access this therapy."

People who meet the PHARMAC eligibility criteria and are approved, will have access to fully funded Medtronic pumps and consumables via pharmacies. For full details on the criteria please visit http://www.pharmac.govt.nz

ENDS

i Bode BW, et al. Diabetes Research and Clin Practice.1999;46:18390.

ii Kaufman FR, et al. DiabetesCare. 2001;24(12):2030.

iii Ludvigsson J, et al. Pediatrics. 2003;111(5 Pt 1):9338.

iv Bode B, et al. Diabetes Technol Ther.2004;6(2):10513.

v Australian Type 1 Diabetes Research Agenda, Juvenile Diabetes Research Foundation, Sydney, 2010.

vi Australian Healthcare Associates Final Report: Insulin Pump Review, 2008.


© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Gordon Campbell: On Chuck Berry (And James Comey, And Bill English)

Back when many people were still treating rock’n’roll as a passing fad – was calypso going to be the new thing? – Chuck Berry knew that it had changed popular music forever. What is even more astonishing is that this 30-ish black r&b musician from a middle class family in St Louis could manage to recreate the world of white teenagers, at a time when the very notion of a “teenager” had just been invented. More>>

Howard Davis Review:
The Baroque Fusion Of L'arpeggiata

Named after a toccata by German composer Girolamo Kapsberger, L'Arpeggiata produces its unmistakable sonority mainly from the resonance of plucked strings, creating a tightly-woven acoustic texture that is both idiosyncratic and immediately identifiable. Director Christina Pluhar engenders this distinctive tonality associated with the ensemble she founded in 2000 by inviting musicians and vocalists from around the world to collaborate on specific projects illuminated by her musicological research. More>>

African Masks And Sculpture: Attic Discovery On Display At Expressions Whirinaki

Ranging from masks studded with nails and shards of glass to statues laden with magical metal, the works are from ethnic groups in nine countries ranging from Ivory Coast to the Democratic Republic of the Congo. More>>

Scoop Review Of Books: We’re All Lab Rats

A couple of years ago, there were reports that Silicon Valley executives were sending their children to tech-free schools. It was a story that dripped of irony: geeks in the heart of techno-utopia rejecting their ideology when it came to their own kids. But the story didn’t catch on, and an awkward question lingered. Why were the engineers of the future desperate to part their gadgets from their children? More>>

  • CensusAtSchool - Most kids have no screen-time limits
  • Netsafe - Half of NZ high school students unsupervised online

  • Obituary: Andrew Little Remembers Murray Ball

    “Murray mined a rich vein of New Zealand popular culture and exported it to the world. Wal and Dog and all the other Kiwi characters he crafted through Footrot Flats were hugely popular here and in Australia, Europe and North America." More>>

    ALSO:

    Organised Choas: NZ Fringe Festival 2017 Awards

    Three more weeks of organised chaos have come to an end with the Wellington NZ Fringe Arts Festival Awards Ceremony as a chance to celebrate all our Fringe artists for their talent, ingenuity, and chutzpah! More>>

    ALSO:

    Wellington.Scoop: Wellington Writer Wins $US165,000 Literature Prize

    Victoria University of Wellington staff member and alumna Ashleigh Young has won a prestigious Windham-Campbell Literature Prize worth USD$165,000 for her book of essays Can You Tolerate This? More>>

    ALSO:

    Scoop Review Of Books: Excerpt - Ice Bear: The Cultural History Of An Arctic Icon

    “During the last decade the image of the polar bear has moved in the public imagination from being an icon of strength, independence and survival in one of the most climatically extreme of world environments, to that of fragility, vulnerability and more generally of a global environmental crisis.” More>>

    Get More From Scoop

     
     

    LATEST HEADLINES

     
     
     
     
    Health
    Search Scoop  
     
     
    Powered by Vodafone
    NZ independent news